Adjuvant Chemotherapy with Traditional Chinese Herbal Granules Versus Placebo in Resected Non-Small Cell Lung Cancer: Updated Survival Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Yichao Wang, Lijing Jiao, Zhiwei Chen, Jianfang Xu, Jiaming Che, Hai Huang, Lei Zhang, Xiaoyong Shen, Yi Yang, Tiancheng Zhao, Jie Zhang, Di Zhou, Qin Wang, Jialin Yao, Wenxiao Yang, Chenbing Sun, Jiaqi Li, Ling Bi, Rongzhen Ding, Ian Goodfellow, Yabin Gong, Ling Xu

Integrative Cancer Therapies

Published online on January 27, 2026

Abstract

Integrative Cancer Therapies, Volume 25, January-December 2026.
Background:The NALLC trial (NCT01441752) demonstrated that postoperative adjuvant chemotherapy combined with traditional Chinese medicine (TCM) improved the quality of life (QoL) and survival in resected stage Ib-IIIa non-small-cell lung cancer (NSCLC) ...